Gender differences in efficacy and sexual function in long-term trazodone treatment (preliminary results)

International Journal of Psychiatry in Clinical Practice

Volumn 10, Issue 3, 2006, Pages 154-159

  Žourková, Alexandra ^a,c   Novotná, Jana ^b  

^a UNIVERSITY HOSPITAL BRNO   (Czech Republic)

^b Psychiatric Clinic   (Czech Republic)

^c MASARYK UNIVERSITY   (Czech Republic)

Author keywords

Correlation; Gender; Sexual dysfunction; Therapeutic efficacy; Trazodone

Indexed keywords

TRAZODONE;

ADULT; ANXIETY; ARTICLE; CLINICAL TRIAL; DEPRESSION; DISEASE SEVERITY; ERECTILE DYSFUNCTION; FEMALE; HUMAN; INCIDENCE; INSOMNIA; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; SEX DIFFERENCE; SEXUAL DYSFUNCTION; SEXUAL FUNCTION; SYSTEMATIC REVIEW; TREATMENT OUTCOME; VAGINAL DRYNESS;

EID: 33745333116     PISSN: 13651501     EISSN: 14711788     Source Type: Journal    
DOI: 10.1080/13651500500443316     Document Type: Article

References (34)

1. Hensley PP, Nurnberg HG. SSRI Sexual dysfunction: A female perspective. J Sex Marital Ther 2002;28:143-53.
2. Kornstein SG, Schatzberg AF, Thase ME, Yonkers KA, McCullough JP, Keitner GI, et al. Gender differences in treatment response to sertraline versus imipramine in chronic depression. Am J Psychiatry 2000;157:1445-52.
3. Baca E, Garcia-Garcia M, Porras-Chavarino A. Gender differences in treatment responses to sertraline versus imipramine in patients with nonmelancholic depressive disorders. Prog Neuropsychopharmacol Biol Psychiatry 2004;28:57-65.
4. Parker G, Parker K, Austin MP, Mitchell P, Brotchie H. Gender differences in response to differing antidepressant drug classes: Two negative studies. Psychol Med 2003;33: 1473-7.
5. Hildebrandt MG, Steyerberg EW, Stage KB, Passchier J, Kragh-Soerensen P. Are gender differences important for the clinical effects of antidepressants? Am J Psychiatry 2003;160: 1643-50.
6. Scheibe S, Preuschhof C, Cristi C, Bagby RM. Are there gender differences in major depression and its response to antidepressants? J Affect Disord 2003;75:223-35.
7. Hawton K, Gath D, Day A. Sexual function in a community sample of middle-age women with partners: Effects of age, marital, socioeconomic, psychiatric, gynecological, and menopausal factors. Arch Sexual Behav 1994;23:375-95.
8. Shen WW, Hsu JH. Female sexual side effects associated with selective serotonin reuptake inhibitors: A descriptive clinical study of 33 patients. Int J Psychiatry Med 1995;25: 239-48.
9. Feiger A, Kiev A, Shrivastava RK, Wisselink PG, Wilcox CS. Nefazodone versus sertraline in outpatients with major depression: Focus on efficacy, tolerability, and effects on sexual function and satisfaction. J Clin Psychiatry 1996; 57(Suppl 2):53-62.
10. Piazza LA, Markowitz JC, Kocsis JH, Leon AC, Portera L, Miller NL, Adler D. Sexual functioning in chronically depressed patients treated with SSRI antidepressants: A pilot study. Am J Psychiatry 1997;154:1757-9.
11. Segraves RT, Balon R. Sexual pharmacology: Fast facts. New York: Norton & Company Inc; 2003.
12. Lingjaerde O, Ahlfors VG, Dencker SJ, Elgen K. The UKU side effects rating scale for psychotropic drugs and a cross sectional study of side effects in antipsychotic patients. Acta Psychiatr Scand 1987; Suppl:1-100.
13. McGahuey CA, Delgado PL, Gelenberg AJ. Assessment of sexual dysfunction using the Arizona sexual experiences scale (ASEX) and implications for the treatment of depression. Psychiatr Ann 1999;29:39-45.
14. Clayton AH, McGarvey EL, Clavet GJ, Piazza L. Comparison of sexual functioning in clinical and nonclinical populations using the Changes in Sexual Functioning questionnaire (CSFQ). Psychophamacol Bull 1997;33:731-45.
15. Gregorian RS, Golden KA, Bahce A, Goodman C, Kwong WJ, Khan ZM. Antidepressant-induced sexual dysfunction. Ann Pharmacother 2002;36:1577-89.
16. Kennedy SH, Eisfeld BS, Dickens SE, Bacchiochi JR, Bagby RM. Antidepressant-induced sexual dysfunction during treatment with moclobemide, paroxetine, sertraline and venlafaxine. J Clin Psychiatry 2000;61:276-81.
17. Altmann M, Kulogla M, Tencan E, Buyukbayenn S. Switching to tianeptine in patients with antidepressant-induced sexual dysfunction. Hum Psychopharmacol 2003;18:s277-80.
18. Clayton AH, Zajecka J, Ferguson JM, Filipiak-Reisner JK, Brown MT, Schwartz GE. Lack of sexual dysfunction with the selective noradrenaline reuptake inhibitor reboxetine during treatment for major depressive disorder. Int Clin Psychopharmacol 2003;18:151-6.
19. Silvestrini B, Cioli V, Burberi S, Cataned B. Pharmacological properties of AF1161, a new psychotropic agent. Int J Neuropharmacol 1968;7:587-99.
20. Burke MJ, Preskorn SH. Short-term treatment of mood disorders with standard antidepressants. In: Bloom FE, Kupfer DJ, editors. Psychopharmacology: The fourth generation of progress. New York: Raven Press; 1995. p 1053-65.
21. World Health Organization. International classification of mental and behavioural disorders. Geneva: WHO; 1992.
22. Guy W. ECDU Assessment Manual for Psychopharmacology. US Dept Health, Education and Welfare publication (ADM). 76-338. Rockville, MD: National Institute of Mental Health; 1976. p 218-22.
23. Weissman NM, Clerman GL. Sex differences and the epidemiology of depression. Arch Gen Psychiatry 1977;34: 98-111.
24. Kornstein SG. Gender differences in depression: Implications for treatment. J Clin Psychiatry 1997;58(Suppl 15): S12-8.
25. Hamilton JA, Grant M, Jensvold MF. Sex and treatment of depression: When does it matter? In: Jensvold MF, Halbreich U, Hamilton JA, editors. Psychopharmacology and women. Washington, DC: American Psychiatric Press; 1996. p 241-57.
26. Frackiewicz EJ, Sramek JJ, Cutler NR. Gender differences in depression and antidepressant pharmacokinetics and adverse events. Ann Pharmacother 1996;34:80-8.
27. Williams JB, Spitzer RL. The issue of sex biasis in DSM III. A critique of 'A woman's view of DSM III' by Marcie Kaplan. Am Psychol 1983;38:793-8.
28. Stahl SM. Essential psychopharmacology. 2nd ed. Cambridge: Cambridge University Press; 2000.
29. Wohlfarth T, Storosum JG, Elferink AJ, van Zwieten BJ, Fouwels A, van den Brink W. Response to tricyclic antidepressants: Independent of gender? Am J Psychiatry 2000; 161:370-2.
30. Weiss P, Zvěřina J. Sexuální chování obyvatel ČR. Prague: Portál; 2001.
31. Meston CM, Gorzalka BB. Psychoactive drugs and human sexual behaviour: The role of serotonergic activity. J Psychoactive Drugs 1992;24:1-40.
32. Perry PJ, Alexander B, Liskow BI, editors. Psychotropic drug handbook. Washington, DC: American Psychiatric Press; 1997.
33. Fink HA, MacDonald R, Rulks IR, Wiet TJ. Trazodone for erectile dysfunction: A systemetic review and meta-analysis. Br J Urol Int 2003;92:441-6.
34. Česková E, Žourková A, Skotá ková S, Kašpárek T. The pitfalls of antidepressant treatment (gender differences). Psychiatrie (Prague) 2004;8(Suppl 4):16-7.